225 related articles for article (PubMed ID: 11788979)
21. Institutional considerations in priority setting: transactions cost perspective on PBMA.
Jan S
Health Econ; 2000 Oct; 9(7):631-41. PubMed ID: 11103929
[TBL] [Abstract][Full Text] [Related]
22. The distribution problem in economic evaluation: income and the valuation of costs and consequences of health care programmes.
Donaldson C; Birch S; Gafni A
Health Econ; 2002 Jan; 11(1):55-70. PubMed ID: 11788982
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness analysis and capital costs.
Karlsson G; Johannesson M
Soc Sci Med; 1998 May; 46(9):1183-91. PubMed ID: 9572608
[TBL] [Abstract][Full Text] [Related]
24. A Framework for Including Family Health Spillovers in Economic Evaluation.
Al-Janabi H; van Exel J; Brouwer W; Coast J
Med Decis Making; 2016 Feb; 36(2):176-86. PubMed ID: 26377370
[TBL] [Abstract][Full Text] [Related]
25. Discounting in health care decision-making: time for a change?
Sheldon TA
J Public Health Med; 1992 Sep; 14(3):250-6. PubMed ID: 1419202
[TBL] [Abstract][Full Text] [Related]
26. Incremental cost-effectiveness ratios (ICERs): the silence of the lambda.
Gafni A; Birch S
Soc Sci Med; 2006 May; 62(9):2091-100. PubMed ID: 16325975
[TBL] [Abstract][Full Text] [Related]
27. A benefit-cost analysis of syringe exchange programs.
Reid RJ
J Health Soc Policy; 2000; 11(4):41-57. PubMed ID: 10620865
[TBL] [Abstract][Full Text] [Related]
28. Ratio-based and net benefit-based approaches to health care resource allocation: proofs of optimality and equivalence.
Laska EM; Meisner M; Siegel C; Stinnett AA
Health Econ; 1999 Mar; 8(2):171-4. PubMed ID: 10342730
[TBL] [Abstract][Full Text] [Related]
29. Generalised cost-effectiveness analysis: an aid to decision making in health.
Hutubessy RC; Baltussen RM; Torres-Edejer TT; Evans DB
Appl Health Econ Health Policy; 2002; 1(2):89-95. PubMed ID: 14619255
[TBL] [Abstract][Full Text] [Related]
30. Risk aversion and uncertainty in cost-effectiveness analysis: the expected-utility, moment-generating function approach.
Elbasha EH
Health Econ; 2005 May; 14(5):457-70. PubMed ID: 15386661
[TBL] [Abstract][Full Text] [Related]
31. Representing uncertainty: the role of cost-effectiveness acceptability curves.
Fenwick E; Claxton K; Sculpher M
Health Econ; 2001 Dec; 10(8):779-87. PubMed ID: 11747057
[TBL] [Abstract][Full Text] [Related]
32. A note on confidence intervals in cost-effectiveness analysis.
Tambour M; Zethraeus N; Johannesson M
Int J Technol Assess Health Care; 1998; 14(3):467-71. PubMed ID: 9780533
[TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness analysis and health care resource allocation: decision rules under variable returns to scale.
Elbasha EH; Messonnier ML
Health Econ; 2004 Jan; 13(1):21-35. PubMed ID: 14724891
[TBL] [Abstract][Full Text] [Related]
34. Estimating CE ratios under second-order uncertainty: the mean ratio versus the ratio of means.
Stinnett AA; Paltiel AD
Med Decis Making; 1997; 17(4):483-9. PubMed ID: 9343807
[TBL] [Abstract][Full Text] [Related]
35. Efficient use of health care resources: the interaction between improved health and reduced health related income loss.
Hoel M
Int J Health Care Finance Econ; 2002 Nov; 2(4):285-96. PubMed ID: 14625995
[TBL] [Abstract][Full Text] [Related]
36. Exploring the costs of a limited public sector antiretroviral treatment programme in South Africa.
Boulle A; Kenyon C; Skordis J; Wood R
S Afr Med J; 2002 Oct; 92(10):811-7. PubMed ID: 12432807
[TBL] [Abstract][Full Text] [Related]
37. Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions.
Adang E; Voordijk L; Jan van der Wilt G; Ament A
Health Policy; 2005 Oct; 74(2):146-56. PubMed ID: 16153475
[TBL] [Abstract][Full Text] [Related]
38. Cost-utility analysis from a societal perspective.
Johannesson M; O'Conor RM
Health Policy; 1997 Mar; 39(3):241-53. PubMed ID: 10165464
[TBL] [Abstract][Full Text] [Related]
39. Extrapolation of cost-effectiveness information to local settings.
Bryan S; Brown J
J Health Serv Res Policy; 1998 Apr; 3(2):108-12. PubMed ID: 10180659
[TBL] [Abstract][Full Text] [Related]
40. Development of WHO guidelines on generalized cost-effectiveness analysis.
Murray CJ; Evans DB; Acharya A; Baltussen RM
Health Econ; 2000 Apr; 9(3):235-51. PubMed ID: 10790702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
